Your session is about to expire
← Back to Search
Behavioral Intervention
VR Brain Training for Traumatic Brain Injury
N/A
Waitlist Available
Led By Duje Tadin, PhD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Control Groups: Between the ages of 18 and 35, and no neurologic or vascular disorders/injuries
Older Adult Group: Over the age of 65, and no neurologic or vascular disorders/injuries
Must not have
Under the age of 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether VR brain training can help improve cognitive function in healthy people and those with TBI.
Who is the study for?
This trial is for adults over 18 with good hearing and vision, who don't play action or VR video games. It includes healthy young adults, older adults without neurological issues, and college athletes recently diagnosed with mild traumatic brain injury (concussion).
What is being tested?
The study compares the effectiveness of brain training exercises when done in Virtual Reality versus on a computer screen. It aims to see if VR can enhance cognitive rehabilitation after a traumatic brain injury.
What are the potential side effects?
Potential side effects may include dizziness, nausea, eye strain or headaches due to virtual reality exposure; however, these are generally mild and temporary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 35 years old and do not have any neurological or vascular disorders.
Select...
I am over 65 and do not have any brain or blood vessel disorders.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am younger than 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Attentional Blink (a measure of temporal resolution of attention)
Useful Field of View (a measure of spacial awareness)
Visual Crowding (a measure of spacial resolution of attention)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: Older Adult GroupExperimental Treatment1 Intervention
Older Adults over the age of 65 who will be training in Virtual Reality
Group II: Control in VRExperimental Treatment1 Intervention
Adults ages 18 to 35 who will be training in Virtual Reality.
Group III: Control Non-VRExperimental Treatment1 Intervention
Adults ages 18 to 35 who will be training on a computer screen.
Group IV: College Athletes with TBI GroupExperimental Treatment1 Intervention
Adults ages 18 to 35 with mild TBI who will be training in Virtual Reality
Find a Location
Who is running the clinical trial?
NeuroTrainerIndustry Sponsor
1 Previous Clinical Trials
155 Total Patients Enrolled
University of RochesterLead Sponsor
867 Previous Clinical Trials
548,802 Total Patients Enrolled
NeurotrainerUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am over 18, can make my own decisions, and have normal or corrected vision and hearing.I am between 18 and 35 years old and do not have any neurological or vascular disorders.I am over 65 and do not have any brain or blood vessel disorders.I am younger than 18 years old.I am a college athlete, aged 18-35, recently diagnosed with a mild brain injury.
Research Study Groups:
This trial has the following groups:- Group 1: Control Non-VR
- Group 2: Control in VR
- Group 3: College Athletes with TBI Group
- Group 4: Older Adult Group
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Share this study with friends
Copy Link
Messenger